[PDF] Minimal Residual Disease An Acute Leukemia - eBooks Review

Minimal Residual Disease An Acute Leukemia


Minimal Residual Disease An Acute Leukemia
DOWNLOAD

Download Minimal Residual Disease An Acute Leukemia PDF/ePub or read online books in Mobi eBooks. Click Download or Read Online button to get Minimal Residual Disease An Acute Leukemia book now. This website allows unlimited access to, at the time of writing, more than 1.5 million titles, including hundreds of thousands of titles in various foreign languages. If the content not found or just blank you must refresh this page





Minimal Residual Disease An Acute Leukemia


Minimal Residual Disease An Acute Leukemia
DOWNLOAD

Author : Bob Löwenberg
language : en
Publisher:
Release Date : 1984

Minimal Residual Disease An Acute Leukemia written by Bob Löwenberg and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 1984 with categories.




Minimal Residual Disease In Acute Leukemia 1986


Minimal Residual Disease In Acute Leukemia 1986
DOWNLOAD

Author : A. Hagenbeek
language : en
Publisher: Springer Science & Business Media
Release Date : 2012-12-06

Minimal Residual Disease In Acute Leukemia 1986 written by A. Hagenbeek and has been published by Springer Science & Business Media this book supported file pdf, txt, epub, kindle and other format this book has been release on 2012-12-06 with Medical categories.


Relapse of leukemia following successful remission-induction therapy remains a major obstacle in the treatment of patients with acute leukemia. Leukemia recurs most frequently in patients with acute myeloblastic leukemia (AML) and high risk acute lymphoblastic leukemia (ALL) following chemotherapy and less often in patients with low risk ALL and particularly in patient groups> submitted to allogeneic marrow transplantation. ' It is likely that the great majority of these recurrences originate from residual leukemic cells that survive initial remission-induction chemotherapy. Today, several research groups throughout the world place emphasis on studies concerned with the detection and treatment of 'minimal residual disease' (MRD). These investigations are conducted with the common objective to tackle the remaining cells. 'Minimal Residual Disease in Acute Leukemia: 1986' summarizes the fast advancements in this area. Several disciplines are concerned with the analysis of leukemic cells. The perspectives of cytogenetic and molecular genetic approaches for applica tion in the detection of MRD are reviewed. In this respect, modern cyto genetics provide highly specific tumor markers. The resolution of cyto genetic methods can be particularly improved when combined with other techniques which select relevant subpopulations of cells. Characterization of oncogenes and gene rearrangements, including those of immunoglobulin and T-cell receptor genes, and the measurement of gene products, have been established. Techniques based on these approaches offer interesting tools for the detection of MRD. New possibilities of employing monoclonal anti bodies are also presented.



Minimal Residual Disease In Acute Leukemia


Minimal Residual Disease In Acute Leukemia
DOWNLOAD

Author :
language : en
Publisher:
Release Date : 1990

Minimal Residual Disease In Acute Leukemia written by and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 1990 with categories.




Leukemia And Lymphoma


Leukemia And Lymphoma
DOWNLOAD

Author : Theodore F. Zipf
language : en
Publisher: Springer Science & Business Media
Release Date : 2002-10-21

Leukemia And Lymphoma written by Theodore F. Zipf and has been published by Springer Science & Business Media this book supported file pdf, txt, epub, kindle and other format this book has been release on 2002-10-21 with Medical categories.


In Leukemia and Lymphoma: Detection of Minimal Residual Disease, hands-on experts describe and discuss the minimal residual disease (MRD) methods they have successfully pioneered for leukemias and lymphomas. They apply reverse transcription PCR (RT-PCR) to acute myeloid leukemia (AML), chronic myelogenous leukemia (CML), and acute promyelocytic leukemia (APL). Other PCR methods are used for Non-Hodgkin's Lymphoma and for the monitoring of follicular lymphoma. Additional chapters address the use of real-time quantitative PCR (RQ-PCR), the emergent method of choice, in patients with acute lymphoblastic leukemia (ALL), the evaluation of MRD techniques in clinical trials, and the application of flow cytometry techniques.



Minimal Residual Disease Testing


Minimal Residual Disease Testing
DOWNLOAD

Author : Todd E. Druley
language : en
Publisher: Springer
Release Date : 2018-11-15

Minimal Residual Disease Testing written by Todd E. Druley and has been published by Springer this book supported file pdf, txt, epub, kindle and other format this book has been release on 2018-11-15 with Medical categories.


This volume provides a concise yet comprehensive overview of minimal residual disease (MRD) testing. The text reviews the history of MRD testing, MRD testing for acute lymphoblastic leukemia/lymphoma, molecular diagnostics for MRD analysis in hematopoietic malignancies, the use of "difference from normal" flow cytometry in monitoring AML response, ML-DS for measurable residual disease detection, and advancements in next generation sequencing for detecting MRD. Written by experts in the field, Minimal Residual Disease Testing: Current Innovations and Future Directions is a valuable resource for hematologists, oncologists, pathologists, and radiologists on the variety of technologies available to detect MRD and how best to integrate these platforms into clinical practice.



Fast Facts Measurable Residual Disease


Fast Facts Measurable Residual Disease
DOWNLOAD

Author : J. Loke
language : en
Publisher: Karger Medical and Scientific Publishers
Release Date : 2021-01-26

Fast Facts Measurable Residual Disease written by J. Loke and has been published by Karger Medical and Scientific Publishers this book supported file pdf, txt, epub, kindle and other format this book has been release on 2021-01-26 with Medical categories.


Conventional methods of detecting disease remission in cancers such as leukemia rely on microscopic analysis of tissue samples. Measurable (or minimal) residual disease (MRD) describes the presence of disease beyond the levels of sensitivity afforded by microscopy. Fast Facts: Measurable Residual Disease describes what is meant by MRD, the opportunities and challenges afforded by its identification and the advantages and disadvantages of the methods used for its detection. Specific examples are given to illustrate the implications of detecting MRD in different disease scenarios, with emphasis on acute myeloid and lymphoblastic leukemias. With the recognition and monitoring of MRD likely to play an increasingly important role in disease prognosis and subsequent treatment direction, this accessible resource is ideal for any healthcare professional wanting to know more about this exciting and fast-moving area. Table of Contents: • What is measurable residual disease? • How is MRD measured? • What is the significance of MRD?



Minimal Residual Disease In Hematologic Malignancies


Minimal Residual Disease In Hematologic Malignancies
DOWNLOAD

Author : Raanani P Ed
language : en
Publisher: S. Karger AG (Switzerland)
Release Date : 2004

Minimal Residual Disease In Hematologic Malignancies written by Raanani P Ed and has been published by S. Karger AG (Switzerland) this book supported file pdf, txt, epub, kindle and other format this book has been release on 2004 with Blood categories.


Detection of minimal residual disease (MRD) is increasingly used in the management of leukemia patients. A wide variety of methods have been developed and include technologies designed to detect residual malignant cells beyond the sensitivity of conventional approaches such as morphology and banding cytogenetics in leukemia. The choice of the best method depends on the biology of the individual malignancy, i.e. on the determination of specific markers which are useful to differentiate between leukemic cells and normal hematopoiesis in leukemic patients. These markers include leukocyte differentiation antigens, fusion transcripts, transcripts overexpressed by mutated or nonmutated genes, rearranged genes, and individual markers like polymorphic repetitive DNA sequences. The major technologies for MRD detection, their advantages and disadvantages and their clinical applications are discussed in this special issue - from 'bench to bedside'. Providing a comprehensive overview on the significance of MRD in the evaluation, treatment and follow-up of hematologic malignancies, it will be of great value to hematologists, researchers interested in leukemias and lymphomas as well as laboratory technicians.



Normal And Malignant B Cell


Normal And Malignant B Cell
DOWNLOAD

Author : Mourad Aribi
language : en
Publisher: BoD – Books on Demand
Release Date : 2020-02-26

Normal And Malignant B Cell written by Mourad Aribi and has been published by BoD – Books on Demand this book supported file pdf, txt, epub, kindle and other format this book has been release on 2020-02-26 with Medical categories.


Normal and Malignant B-Cell is a collection of harmonious chapters contributed by different authors. This book sets out to describe the B-cell during different stages of ontogeny and the molecular mechanisms of its antigen receptor diversity. It also discusses the main clinical and etiopathogenic aspects when it is transformed into a malignant cell. The book will be interesting and useful for clinicians, biologists, researchers, teachers, and graduate students of both doctoral and master's degrees in the field of immunology.



Clinical Management Of Acute Lymphoblastic Leukemia


Clinical Management Of Acute Lymphoblastic Leukemia
DOWNLOAD

Author : Mark R. Litzow
language : en
Publisher: Springer Nature
Release Date : 2022-01-01

Clinical Management Of Acute Lymphoblastic Leukemia written by Mark R. Litzow and has been published by Springer Nature this book supported file pdf, txt, epub, kindle and other format this book has been release on 2022-01-01 with Medical categories.


This book provides a state-of-the-art overview of acute lymphoblastic leukemia (ALL). The first section of the book presents the translational science behind ALL, reviewing molecular pathways and targets in B- and T-cell ALL, as well as techniques and application of minimal residual disease testing. The second section spotlights ALL management strategies for patients across the spectrum, from infants to the elderly. The final section outlines current and new advances in ALL treatment, including new monoclonal antibodies and allogenic and autologous HSCT. Written by experts in the field, Clinical Management of Acute Lymphoblastic Leukemia: From Bench to Bedside is a valuable resource that will guide patient management, stimulate investigative efforts, and increase understanding of the biologic underpinnings of the disease.



Hematologic Malignancies Acute Leukemias


Hematologic Malignancies Acute Leukemias
DOWNLOAD

Author : S.H. Faderl
language : en
Publisher: Springer Science & Business Media
Release Date : 2007-11-21

Hematologic Malignancies Acute Leukemias written by S.H. Faderl and has been published by Springer Science & Business Media this book supported file pdf, txt, epub, kindle and other format this book has been release on 2007-11-21 with Medical categories.


Better therapy of acute leukemias depends ultimately on better understanding of the distinction between leukemic and normal progenitor cells. This hugely important new book describes the current knowledge of acute leukemia biology and discusses new classification systems that have arisen as a result of emerging insights into pathogenesis. Estey, Faderl and Kantarjian, who all work at the respected Anderson Cancer Center in Houston, Texas, USA, examine in detail advances in the treatment of particular types of acute leukemia. Their book also covers the management of acute leukemia in general as well as the development of new therapies. This book will be extremely useful to clinicians.